- Research works
- 66 ▼ 31% vs 2013–17
- Citations
- 1.5k 22.4 per fractional work
- Top-10% rate
- 4.5% record average 16.5%
- Open access
- 49% world 28%
Not ranked overall: PamGene (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.1×. Every wedge is a field page.
Who are the top researchers at PamGene (Netherlands)?
Ranked on the composite score, Riet Hilhorst, John P. Groten and Rob Ruijtenbeek lead among researchers whose main affiliation is PamGene (Netherlands).
- 1 Riet Hilhorst Netherlands · #574,986 worldwide 104 citations · 31 works
- 2 John P. Groten Netherlands · #1,021,888 worldwide 65 citations · 16 works
- 3 Rob Ruijtenbeek Netherlands · #1,491,466 worldwide 17 citations · 17 works
- 4 René Houtman Netherlands · #1,577,797 worldwide 10 citations · 16 works
Which keywords describe research at PamGene (Netherlands)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Transcriptional Regulation, Breast Cancer, Nuclear Receptors, Glycosylation, Signaling, Inflammation and Chemotherapy.
- Protein-Protein Interactions
- Immune Regulation
- Mucins
- Microarray
- Differential Expression
- Drug Discovery
- Immune System
- Precision Medicine
- Metastatic
- Data Analysis
- Tumor Microenvironment
- Fc Receptors
- Protein Microarrays
- Immunotherapy
- Glucocorticoids
- Estrogen
- Chemotherapy
- Glycosylation
- Breast Cancer
- Transcriptional Regulation
- Cancer
- Inflammation
- Nuclear Receptors
- Signaling
- Receptor
- Gene Expression
- Machine Learning
- High-Throughput Analysis
- Cancer Therapy
- Therapeutic Antibodies
- Prognostic Factors
- Targeted Therapy
- Normalization
- Angiogenesis
- BRAF Mutation
- Quantitative Analysis
- Glycans
- Monoclonal Antibody
- Cell Signaling
- Molecular Subtypes
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer7▲ 8.0×19 topics
- Transcriptional Regulation7▲ 40×7 topics
- Inflammation6▲ 3.8×22 topics
- Breast Cancer5▲ 29×4 topics
- Nuclear Receptors5▲ 43×5 topics
- Glycosylation5▲ 35×3 topics
- Signaling5▲ 63×4 topics
- Chemotherapy4▲ 8.6×7 topics
- Receptor4▲ 81×2 topics
- Estrogen4▲ 72×1 topic
- Gene Expression4▲ 8.9×8 topics
- Glucocorticoids4▲ 97×1 topic
- Machine Learning4▲ 2.4×4 topics
- Immunotherapy3▲ 7.4×9 topics
- High-Throughput Analysis3▲ 102×1 topic
- Protein Microarrays3▲ 235×1 topic
- Cancer Therapy3▲ 7.2×10 topics
- Fc Receptors3▲ 44×1 topic
- Therapeutic Antibodies3▲ 34×1 topic
- Tumor Microenvironment3▲ 13×7 topics
- Prognostic Factors3▲ 8.9×8 topics
- Data Analysis3▲ 12×3 topics
- Targeted Therapy3▲ 18×5 topics
- Metastatic2▲ 58×2 topics
- Normalization2▲ 50×2 topics
- Precision Medicine2▲ 11×3 topics
- Angiogenesis2▲ 8.2×6 topics
- Immune System2▲ 10×2 topics
- BRAF Mutation2▲ 44×2 topics
- Drug Discovery2▲ 7.6×4 topics
- Quantitative Analysis2▲ 18×2 topics
- Differential Expression2▲ 96×1 topic
- Glycans2▲ 35×1 topic
- Microarray2▲ 96×1 topic
- Monoclonal Antibody2▲ 40×2 topics
- Mucins2▲ 35×1 topic
- Cell Signaling2▲ 8.1×5 topics
- Immune Regulation2▲ 20×3 topics
- Molecular Subtypes2▲ 31×2 topics
- Protein-Protein Interactions2▲ 25×3 topics
Which research topics does PamGene (Netherlands) publish most on?
By volume in 2022–2025: Colorectal Cancer Treatments and Studies, interferon and immune responses, Estrogen and related hormone effects and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Colorectal Cancer Treatments and Studies Oncology 1 works
- 2 interferon and immune responses Immunology 0 works
- 3 Estrogen and related hormone effects Genetics 0 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 5 S100 Proteins and Annexins Molecular Biology 0 works
- 6 Retinal Development and Disorders Molecular Biology 0 works
- 7 Cancer-related Molecular Pathways Oncology 0 works
- 8 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 0 works
- 9 Retinal Diseases and Treatments Ophthalmology 0 works
- 10 CAR-T cell therapy research Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has PamGene (Netherlands)'s research output changed?
Output in 2018–2022 was 31% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in 's-Hertogenbosch
- Food & Nutrition
- Jeroen Bosch Ziekenhuis
- Netherlands Pharmacovigilance Centre Lareb
- Reinier van Arkel
- Expertise Center Vocational Education
- HAS green academy
- GGD Hart voor Brabant
- Essent (Netherlands)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.